TY  - GEN
AU  - Nakamura,R
AU  - Rodriguez,R
AU  - Palmer,J
AU  - Stein,A
AU  - Naing,A
AU  - Tsai,N
AU  - Chang,K
AU  - Slovak,M L
AU  - Bhatia,R
AU  - Spielberger,R
AU  - Kogut,N
AU  - Pullarkat,V
AU  - Kirschbaum,M
AU  - Forman,S J
AU  - O'Donnell,M R
TI  - Reduced-intensity conditioning for allogeneic hematopoietic stem cell transplantation with fludarabine and melphalan is associated with durable disease control in myelodysplastic syndrome
SN  - 0268-3369
PY  - 2007///1219
KW  - Adult
KW  - Aged
KW  - Graft Survival
KW  - Graft vs Host Disease
KW  - Hematologic Diseases
KW  - therapy
KW  - Hematopoietic Stem Cell Transplantation
KW  - adverse effects
KW  - Humans
KW  - Melphalan
KW  - therapeutic use
KW  - Middle Aged
KW  - Myelodysplastic Syndromes
KW  - complications
KW  - Retrospective Studies
KW  - Survival Analysis
KW  - Transplantation Conditioning
KW  - methods
KW  - Transplantation, Homologous
KW  - Treatment Outcome
KW  - Vidarabine
KW  - analogs & derivatives
N1  - Publication Type: Journal Article
UR  - https://doi.org/10.1038/sj.bmt.1705801
ER  -